Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp |
| Completed | 1 | 20 | Europe | Budesonide/formoterol 320/9 μg and 400/12 μg inhalers, Symbicort 320/9 μg inhaler | Orion Corporation, Orion Pharma | Asthma | 10/10 | 11/10 | | |
| Completed | 1 | 20 | Europe | Budesonide/formoterol capsule., Budesonide/formoterol capsule for oral adm. | Orion Corporation, Orion Pharma | Asthma | 10/11 | 10/11 | | |
NCT01386996: Comparison of Budesonide and Formoterol Absorption From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler |
|
|
| Completed | 1 | 74 | Europe | Budesonide/formoterol Easyhaler 320/9 microg, Symbicort Turbuhaler forte | Orion Corporation, Orion Pharma | Asthma | 11/11 | 11/11 | | |
NCT01593826: Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler |
|
|
| Completed | 1 | 72 | Europe | Charcoal and Budesonide/formoterol Easyhaler 320/9 microg, Charcoal and Symbicort Turbuhaler, Budesonide/formoterol Easyhaler 320/9 microg, Symbicort Turbuhaler forte | Orion Corporation, Orion Pharma | Asthma | 10/12 | 10/12 | | |
ADECO, NCT01627158: Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte |
|
|
| Completed | 1 | 72 | Europe | Budesonide/formoterol Easyhaler, Symbicort Turbuhaler, Charcoal and Budesonide/formoterol Easyhaler, Charcoal and Symbicort Turbuhaler | Orion Corporation, Orion Pharma | Asthma | 10/12 | 10/12 | | |
REFLI, NCT01668121: Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers |
|
|
| Completed | 1 | 48 | Europe | Symbicort Turbohaler, Budesonide/formoterol Easyhaler | Orion Corporation, Orion Pharma | Asthma | 11/12 | 11/12 | | |
NCT03073057: Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler |
|
|
| Completed | 1 | 20 | Europe | Budesonide/formoterol, Budesonide/formoterol 160/4.5microg, Charcoal, Symbicort Turbuhaler, Symbicort Turbuhaler 160/4.5 microg | Orion Corporation, Orion Pharma | Asthma | 03/16 | 03/16 | | |